From
StayCurrentMD
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
With Dr. Sophia Schermerhorn
Chapter 1 of 1 · Evidence & Research
Cisplatin Retreatment in Relapsed Hepatoblastoma
Cued at 0:59 · press play
Expert statements on this page
No expert statements were drawn from this page.
Host summaries · secondary, not cited in answers
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Video
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
1 min · Published Jan 2026
Video
BOB Ped Surg 2023 - Andrew Fleming, AAP - Presentation
Published Feb 2023
Video
Indocyanine green is a sensitive adjunct in the identification and surgical management of local and metastatic hepatoblastoma
1 min · Published Jan 2026
Video
Aggressive Pursuit of No Evidence of Disease Status in Hepatoblastoma Improves Survival
Published Jun 2023
Video
La búsqueda agresiva de ausencia de evidencia del estado de la enfermedad en el hepatoblastoma mejora la supervivencia
Published Jun 2023
Video
Hepatoblastoma: Update Course 2014
24 min · Published Nov 2018
Video
Rare Ovarian Tumor in Infants: Small Cell Carcinoma of Ovary, Hypercalcemic Type & SMARCA4 Mutation
21 s · Published Oct 2026
Video
Can Normal X-Rays Miss Metastatic Neuroblastoma? A Pediatric Radiology Case Study
26 s · Published Oct 2026
Video
Can Fractures Be a Sign of Hepatoblastoma in Children? Understanding Pediatric Liver Cancer Symptoms
37 s · Published Oct 2026
Podcast
Hepatoblastoma
Todd Ponsky · 54 min · Published Oct 2026
Podcast
Wilms Tumor
Todd Ponsky · 64 min · Published Oct 2026
Podcast
Neuroblastoma
Todd Ponsky · 56 min · Published Oct 2026
Video
Clinical & Research Update: Neuroblastoma with Drs. Katherine Somers, Cara Morin, Juan Gurria, and Meera Kotagal
67 min · Published Sep 2026
Video
Indocyanine green assists with sentinel lymph node mapping in pediatric and adolescent patients
1 min · Published May 2026
Video
Pancreas, Muscle, and Subcutaneous Fat Atrophy in Patients Undergoing Radiation for Neuroblastoma
1 min · Published Apr 2026
Video
Clinical & Research Update: Pediatric Liver Tumors - A Case-Based Discussion with Drs. Katherine Somers & Alex Bondoc
69 min · Published Apr 2026
Video
Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?
1 min · Published Feb 2026
Video
Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma
1 min · Published Feb 2026
Podcast
Diaphragm pacing as alternative to mechanical ventilation in pediatric respiratory failure
1 min · Published Nov 2026
Podcast
Severe CDH case with FETO: unexpected anatomic findings and clinical outcome
3 min · Published Nov 2026
Podcast
Managing pancreatic fluid collections and chronic pancreatitis complications in children
2 min · Published Nov 2026
Podcast
FETO procedure for late-diagnosed severe CDH with liver herniation
4 min · Published Nov 2026
Podcast
Acute pancreatitis in children: early feeding and step-up surgical approach
3 min · Published Nov 2026
Podcast
Fetoscopic endoluminal tracheal occlusion for congenital diaphragmatic hernia
4 min · Published Nov 2026
What the experts said
There is no established standard salvage therapy regimen for relapsed hepatoblastoma
The Cincinnati Children's retrospective review of 30 patients represents one of the largest published cohorts evaluating patients with refractory or recurrent hepatoblastoma
The overall survival for the cohort was about 50%
Children who received cisplatin as part of their salvage therapy had survival of about 80% compared to 25% for those who did not receive cisplatin
The improved survival outcomes with cisplatin may be due to persistent platinum sensitivity or better tumor biology rather than proving causality
Most patients underwent additional surgery as part of their salvage therapy, either liver resection, liver transplant, or pulmonary metastasectomy
Salvage therapy for relapsed hepatoblastoma is multimodal
Cisplatin retreatment should be balanced with the risk of cumulative toxicity